ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
61,412.81
0.37%
S&P 500
5,187.67
0.00%
Dow Jones
39,056.39
0.44%
US Dollar vs Yen
155.491
0.04%
Brent Oil
83.705
0.17%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Alaunos Therapeutics Inc (TCRT)

  7. Alaunos Therapeutics Inc (TCRT) ニュース

TCRT

Alaunos Therapeutics (TCRT)

Alaunos Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:TCRT
日付受信時刻ニュースソース見出しコード企業名
2024/02/2911 : 46Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
2024/02/2306 : 44Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
2024/02/2106 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
2024/02/1502 : 43Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TCRTAlaunos Therapeutics Inc
2024/02/1406 : 58Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TCRTAlaunos Therapeutics Inc
2024/01/2922 : 45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
2024/01/2407 : 47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
2024/01/2306 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
2024/01/0407 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
2024/01/0407 : 25Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
2024/01/0222 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
2023/12/2906 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
2023/12/2222 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
2023/11/1521 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
2023/11/1421 : 30GlobeNewswire Inc.Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic AlternativesNASDAQ:TCRTAlaunos Therapeutics Inc
2023/09/2905 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
2023/09/0606 : 34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
2023/09/0201 : 20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
2023/08/1505 : 37Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TCRTAlaunos Therapeutics Inc
2023/08/1505 : 16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
2023/08/1505 : 05GlobeNewswire Inc.Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic AlternativesNASDAQ:TCRTAlaunos Therapeutics Inc
2023/06/2920 : 00GlobeNewswire Inc.Alaunos Therapeutics Announces Presentation at the 2nd Hawaii Global Summit on Thoracic MalignanciesNASDAQ:TCRTAlaunos Therapeutics Inc
2023/06/1305 : 16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCRTAlaunos Therapeutics Inc
2023/06/0906 : 25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRTAlaunos Therapeutics Inc
2023/06/0906 : 24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRTAlaunos Therapeutics Inc
2023/05/2606 : 00GlobeNewswire Inc.Alaunos Therapeutics to Present Early Data from TCR-T Library Phase 1/2 Trial at 2023 American Society of Clinical Oncology Annual MeetingNASDAQ:TCRTAlaunos Therapeutics Inc
2023/05/1020 : 32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TCRTAlaunos Therapeutics Inc
2023/05/1020 : 00GlobeNewswire Inc.Alaunos Therapeutics Reports First Quarter 2023 Financial ResultsNASDAQ:TCRTAlaunos Therapeutics Inc
2023/05/0321 : 30GlobeNewswire Inc.Alaunos Therapeutics to Report First Quarter 2023 Financial Results on May 10, 2023NASDAQ:TCRTAlaunos Therapeutics Inc
2023/04/2701 : 30GlobeNewswire Inc.Alaunos Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology (ASCO) 2023 Annual MeetingNASDAQ:TCRTAlaunos Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TCRT

最近閲覧した銘柄

PM
XAUUSD
Gold vs US Dollar
COIN
ETHUSD
Ethereum
NYSE
AXP
American Express
NYSE
JPM
JP Morgan Chase
FX
USDGBP
US Dollar vs Sterling
USOTC
RHHBY
Roche (QX)
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
NVDA
NVIDIA
NYSE
VZ
Verizon Communications
USOTC
BASFY
BASF (QX)
NYSE
MRK
Merck
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
MCD
McDonalds
FX
USDJPY
US Dollar vs Yen
CCOM
SILVER
SILVER
AMEX
SPY
SPDR S&P 500
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有